AI assistant
SYNOPSYS INC — Director's Dealing 2022
May 27, 2022
29855_dirs_2022-05-27_5a14f2e6-c510-4e37-bece-fdaa0ec44be4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2022-05-25
Reporting Person: Pham Trac (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-25 | Common Stock | M | 25000 | $89.76 | Acquired | 83204 | Direct |
| 2022-05-25 | Common Stock | S | 25000 | $299.36 | Disposed | 58204 | Direct |
| 2022-05-26 | Common Stock | M | 4529 | $234.17 | Acquired | 62733 | Direct |
| 2022-05-26 | Common Stock | S | 4529 | $305.0 | Disposed | 58204 | Direct |
| 2022-05-26 | Common Stock | M | 24643 | $135.88 | Acquired | 82847 | Direct |
| 2022-05-26 | Common Stock | S | 24643 | $305.0 | Disposed | 58204 | Direct |
| 2022-05-26 | Common Stock | M | 19900 | $89.76 | Acquired | 78104 | Direct |
| 2022-05-26 | Common Stock | S | 19900 | $305.0 | Disposed | 58204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | Non-Qualified Stock Option (right to buy) | $89.76 | M | 25000 | Disposed | 2025-12-12 | Common Stock (25000) | Direct |
| 2022-05-26 | Non-Qualified Stock Option (right to buy) | $89.76 | M | 19900 | Disposed | 2025-12-12 | Common Stock (19900) | Direct |
| 2022-05-26 | Non-Qualified Stock Option (right to buy) | $135.88 | M | 24643 | Disposed | 2026-12-12 | Common Stock (24643) | Direct |
| 2022-05-26 | Non-Qualified Stock Option (right to buy) | $234.17 | M | 4529 | Disposed | 2027-12-10 | Common Stock (4529) | Direct |
Footnotes
F1: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $298.34 to $301.56. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.